Cargando…

Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary study

BACKGROUND: Rivaroxaban, a novel oral anticoagulant drug, is widely used in clinical practice. There is no standardized laboratory monitoring for rivaroxaban, and its plasma concentration in Chinese patients with deep vein thrombosis is unclear. The rivaroxaban concentrations in human plasma and det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ying, Du, Liping, Tang, Xiaowan, Chen, Yuexin, Mei, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257180/ https://www.ncbi.nlm.nih.gov/pubmed/32466800 http://dx.doi.org/10.1186/s40360-020-00414-5

Ejemplares similares

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
por: Çiçek, Necati, et al.
Publicado: (2021)

Rivaroxaban for the treatment of cerebral venous thrombosis
por: Esmaeili, Sara, et al.
Publicado: (2021)

Treatment of central venous catheter‐associated deep venous thrombosis in cancer patients with rivaroxaban
por: Laube, Eva S., et al.
Publicado: (2016)

Use of oral rivaroxaban in cerebral venous thrombosis
por: Maqsood, Muhammad, et al.
Publicado: (2020)

Efficacy and Safety Assessment of Rivaroxaban for the Treatment of Cerebral Venous Sinus Thrombosis in a Chinese Population
por: Jiang, Yi-ying, et al.
Publicado: (2022)

The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019)

A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty
por: Dong, Yongyong, et al.
Publicado: (2022)

Retracted: A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban
por: Piati, Polyana Klomfass, et al.
Publicado: (2019)

Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban
por: Boban, Ana, et al.
Publicado: (2016)

An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis
por: Fatima, Meraj, et al.
Publicado: (2021)

Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus
Publicado: (2018)

Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus
por: Ma, Junhao, et al.
Publicado: (2017)

Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy
por: Dong, Qinhui, et al.
Publicado: (2022)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Treatment Failure of Cerebral Venous Thrombosis With Rivaroxaban: A Case Report and Narrative Review
por: Mohamed, Mustafa, et al.
Publicado: (2022)

Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: A case report
por: Li, Yan, et al.
Publicado: (2019)

The prevalence of deep venous thrombosis in Chinese medical ICU patients
por: Joynt, GM, et al.
Publicado: (2003)

Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism
por: UCHIDA, Mona, et al.
Publicado: (2020)

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
por: Wang, Yuqi, et al.
Publicado: (2013)

Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis
por: Zheng, Dandan, et al.
Publicado: (2022)

Rivaroxaban versus nadroparin for preventing deep venous thrombosis after total hip arthroplasty following femoral neck fractures: A retrospective comparative study
por: Zhang, Chi, et al.
Publicado: (2018)

Rivaroxaban after Thrombolysis in Acute Iliofemoral Venous Thrombosis: A Randomized, Open-labeled, Multicenter Trial
por: Kang, Jin Mo, et al.
Publicado: (2019)

Rivaroxaban for cancer-associated venous thromboembolism
por: Liang, Bo, et al.
Publicado: (2021)

Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
por: Koitabashi, Norimichi, et al.
Publicado: (2015)

Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
por: Naito, Tomoyuki, et al.
Publicado: (2018)

Laboratory assessment of rivaroxaban: a review
por: Samama, Meyer Michel, et al.
Publicado: (2013)

Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution
por: Cheng, Xi, et al.
Publicado: (2021)

Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis
por: Motaganahalli, Raghu L., et al.
Publicado: (2021)

The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
por: Lv, Shoutian, et al.
Publicado: (2019)

Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations
por: Marone, Enrico M., et al.
Publicado: (2020)

Fatigue after initiating rivaroxaban for venous thromboembolism
por: Karlsvik, Tina Margrethe, et al.
Publicado: (2020)

Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment
por: Yuksel, Murat, et al.
Publicado: (2015)

Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?
por: Xavier, Flávia Dias, et al.
Publicado: (2016)

Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial
por: Song, Runze, et al.
Publicado: (2021)

A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia
por: Derseh, Manaye Tamrie, et al.
Publicado: (2021)

Case report: Chlorpromazine and deep venous thrombosis
por: Reed, Matthew Joseph, et al.
Publicado: (2019)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Speed, Victoria, et al.
Publicado: (2021)

Chronic Stress Facilitates the Development of Deep Venous Thrombosis
por: Dong, Tao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i7ihbo4taljkkrqh1r08t36f7j